|
C6ORF192 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.275900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.237100E-03 |
| Normal-vs-Stage2 |
8.502200E-01 |
| Normal-vs-Stage3 |
5.187600E-04 |
| Normal-vs-Stage4 |
1.007560E-01 |
| Stage1-vs-Stage2 |
7.622100E-02 |
| Stage1-vs-Stage3 |
9.668400E-02 |
| Stage1-vs-Stage4 |
8.912800E-01 |
| Stage2-vs-Stage3 |
8.896700E-03 |
| Stage2-vs-Stage4 |
2.429000E-01 |
| Stage3-vs-Stage4 |
2.764600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.944500E-03 |
| Normal-vs-AfricanAmerican |
1.776030E-01 |
| Normal-vs-Asian |
7.504200E-02 |
| Caucasian-vs-AfricanAmerican |
1.656990E-01 |
| Caucasian-vs-Asian |
7.288600E-01 |
| AfricanAmerican-vs-Asian |
4.554400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.122300E-02 |
| Normal-vs-Female |
1.355430E-03 |
| Male-vs-Female |
1.004560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.204000E-02 |
| Normal-vs-Extreme_Weight |
3.624100E-03 |
| Normal-vs-Obese |
2.877700E-02 |
| Normal-vs-Extreme_Obese |
5.201200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.686200E-01 |
| Normal_Weight-vs-Obese |
9.922400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.871600E-01 |
| Extreme_Weight-vs-Obese |
5.647400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.516200E-01 |
| Obese-vs-Extreme_Obese |
6.821000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.579400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.980950E-03 |
| Normal-vs-Age(61-80Yrs) |
5.568000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.033840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.473600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.776300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.654400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.112640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.718800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.724800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.550100E-02 |
| Normal-VS-Type2 PRCC |
5.844300E-04 |
| Normal-VS-KIRP CIMP |
1.032060E-02 |
| Normal-VS-Unclassified PRCC |
7.890500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.280100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.851500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.680800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.789800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.615420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.463160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.550100E-04 |
| Normal-vs-N1 |
3.763500E-03 |
| Normal-vs-N2 |
1.327670E-02 |
| N0-vs-N1 |
7.379800E-01 |
| N0-vs-N2 |
2.615800E-01 |
| N1-vs-N2 |
1.087020E-01 |
|
|
